Boosting BCG vaccinated mice via intranasal or intratracheal administration of nanoparticles coated with Mtb antigens was also found to induce CD69+CD103+ TB-specific lung Trm compared to subcutaneous BCG alone or uncoated nanoparticle (113). This evidence concerns the gene CD69 and tuberculosis.